Understanding the Risk of Joint Replacement in Patients With Rheumatoid Arthritis

August 29th 2020, 1:00pm


Despite progress from disease-modifying antirheumatic drugs, there is still a far greater long-term risk of undergoing total knee and hip arthroplasties in patients with rheumatoid arthritis.

Patients With Lupus, Inflammatory Arthritis Have Similar Risk of COVID-19 Hospitalization as General Population

August 28th 2020, 12:40pm


Most people with systemic lupus erythematosus and inflammatory arthritis, who use medications that make them immunosuppressed, are not necessarily at greater risk of hospitalization from coronavirus disease 2019 (COVID-19), according to 2 studies.

FDA Rejects Gilead’s Filgotinib for RA, Requests More Data

August 20th 2020, 8:30pm


In a Complete Response Letter, FDA is requesting additional data from Gilead Sciences for its investigational treatment for moderately to severely active rheumatoid arthritis (RA).

Autoimmune Pipelines Drive Acquisitions by Sanofi and Johnson & Johnson

August 19th 2020, 8:37pm


Sanofi and Johnson & Johnson are making moves to expand their autoimmune portfolios with recently announced acquisitions.

Clinical Remission Does Not Always Mean Imaging Remission in Rheumatoid Arthritis

August 15th 2020, 2:00pm


A new study of patients with rheumatoid arthritis (RA) in Korea has shown that only about half of patients with RA who attained clinical remission were also in imaging remission.

Factors Associated With Severe COVID-19 in Patients With Rheumatic Diseases

August 14th 2020, 6:11pm


Patients with connective tissue diseases are at greater risk for severe coronavirus disease 2019 (COVID-19) than patients with chronic inflammatory arthritis.

Fatigue Broadly Impacts Patients With RA, Psoriatic Arthritis, Axial Spondyloarthritis

August 8th 2020, 2:00pm


A new study in PLOS ONE has highlighted the broad impact fatigue can have on patients with rheumatoid arthritis (RA), psoriatic arthritis, and axial spondyloarthritis.

Specialty Drug Spending After State-Mandated Out-of-Pocket Caps

August 6th 2020, 5:13pm


Despite concerns, legislation to cap out-of-pocket payments for specialty drugs has not been shown to shift costs to health plans, thereby increasing insurance premiums, according to a study published in New England Journal of Medicine.

Transitioning Adolescents With Lupus From Pediatric to Adult Care

July 23rd 2020, 8:52pm


Transferring from pediatric to adult care can result in difficulties for patients with childhood-onset systemic lupus erythematosus.

Evaluating the Presence and Impact of Comorbidities in Rheumatoid Arthritis

July 22nd 2020, 1:37am


Comorbidities are common in patients with rheumatoid arthritis, and the presence of comorbidities reduces the chance of remission and is associated with worse functional status and disease activity measures.